Report of the WHO Technical Consultation on the Evaluation of Respiratory Syncytial Virus Prevention Cost Effectiveness in Low- and Middle-Income Countries, April 7-8, 2022.
Vaccine(2023)
关键词
Keywords,Cost effectiveness,Global health,Monoclonal antibody,Respiratory syncytial virus,Vaccine
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要